When is ESLAW next annual earnings release?

As of today, the next annual earnings release for ESLAW has not been scheduled

When is ESLAW next earnings release?

As of today, the next earnings release for ESLAW has not been scheduled

Name: Estrella Immunopharma, Inc. (ESLAW) Debt To Equity Ratio History
License: https://wallstreetnumbers.com/terms-and-conditions

N/A

March 31, 2026

ESLAW Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Debt To Equity	Mar 31, 26	-	–	–	–	–
Annual Debt To Equity	Dec 31, 25	-	–	–	–	–
Price	Aug 24, 26	$0.08	-37.1%	+107.2%	–	–
Quarterly Total Debt	Mar 31, 26	-	–	–	–	–
Quarterly Shareholders Equity	Mar 31, 26	-$5.27M	+49.2%	-187.8%	-223.3%	+18.6%
Quarterly Current Ratio	Mar 31, 26	0.24	+100.0%	+9.1%	-99.0%	-62.5%
Quarterly Quick Ratio	Mar 31, 26	-	–	–	–	–
Quarterly Short Term Debt	Mar 31, 26	-	–	–	–	–
Quarterly Long Term Debt	Mar 31, 26	-	–	–	–	–
Piotroski F-Score	Mar 31, 26	-	–	–	–	–
Altman Z-Score	Aug 24, 26	-	–	–	–	–

ESLAW Quarterly Debt To Equity Highs Comparison
Period	High	Date	Current
1Y	N/A	N/A	N/A
3Y	-0.01	N/A	N/A
5Y	-0.01	Dec 31, 22	N/A
All	-0.01	Dec 31, 22	N/A

ESLAW Quarterly Debt To Equity Lows Comparison
Period	Low	Date	Current
1Y	N/A	N/A	N/A
3Y	-0.01	N/A	N/A
5Y	-0.01	Dec 31, 22	N/A
All	-0.01	Dec 31, 22	N/A

Month	Value	Change
Dec 2022	-0.01	-

When is ESLAW next earnings release?: As of today, the next earnings release for ESLAW has not been scheduled

Debt To Equity =